Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas.

Chandra S, Barth RF, Haider SA, Yang W, Huo T, Shaikh AL, Kabalka GW.

PLoS One. 2013 Sep 18;8(9):e75377. doi: 10.1371/journal.pone.0075377. eCollection 2013.

PMID:
24058680
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Biological evaluation of boronated unnatural amino acids as new boron carriers.

Kabalka GW, Yao ML, Marepally SR, Chandra S.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S374-9. doi: 10.1016/j.apradiso.2009.03.104. Epub 2009 Apr 2.

PMID:
19398346
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).

Chandra S, Ahmad T, Barth RF, Kabalka GW.

J Microsc. 2014 Jun;254(3):146-56. doi: 10.1111/jmi.12126. Epub 2014 Mar 31.

PMID:
24684609
[PubMed - in process]
4.

Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.

Barth RF, Yang W, Al-Madhoun AS, Johnsamuel J, Byun Y, Chandra S, Smith DR, Tjarks W, Eriksson S.

Cancer Res. 2004 Sep 1;64(17):6287-95.

PMID:
15342417
[PubMed - indexed for MEDLINE]
Free Article
5.

Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.

Hsieh CH, Chen YF, Chen FD, Hwang JJ, Chen JC, Liu RS, Kai JJ, Chang CW, Wang HE.

J Nucl Med. 2005 Nov;46(11):1858-65.

PMID:
16269600
[PubMed - indexed for MEDLINE]
Free Article
6.

Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.

Smith DR, Chandra S, Barth RF, Yang W, Joel DD, Coderre JA.

Cancer Res. 2001 Nov 15;61(22):8179-87.

PMID:
11719448
[PubMed - indexed for MEDLINE]
Free Article
7.

Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas.

Barth RF, Kabalka GW, Yang W, Huo T, Nakkula RJ, Shaikh AL, Haider SA, Chandra S.

Appl Radiat Isot. 2014 Jun;88:38-42. doi: 10.1016/j.apradiso.2013.11.133. Epub 2013 Dec 12.

PMID:
24393770
[PubMed - in process]
8.

In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.

Liu L, Barth RF, Tjarks W, Soloway AH, Anisuzzaman AK.

Anticancer Res. 1996 Jan-Feb;16(1):113-20.

PMID:
8615595
[PubMed - indexed for MEDLINE]
9.

Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy.

Kabalka GW, Shaikh AL, Barth RF, Huo T, Yang W, Gordnier PM, Chandra S.

Appl Radiat Isot. 2011 Dec;69(12):1778-81. doi: 10.1016/j.apradiso.2011.03.035. Epub 2011 Mar 31.

PMID:
21481596
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.

Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):209-18.

PMID:
10758326
[PubMed - indexed for MEDLINE]
11.

Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.

Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA.

Cancer Res. 2002 Jun 1;62(11):3159-66.

PMID:
12036929
[PubMed - indexed for MEDLINE]
Free Article
12.

Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation.

Barth RF, Yang W, Coderre JA.

J Neurooncol. 2003 Mar-Apr;62(1-2):61-74. Review.

PMID:
12749703
[PubMed - indexed for MEDLINE]
13.

Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).

Chandra S, Tjarks W, Lorey DR 2nd, Barth RF.

J Microsc. 2008 Jan;229(Pt 1):92-103. doi: 10.1111/j.1365-2818.2007.01869.x.

PMID:
18173648
[PubMed - indexed for MEDLINE]
14.

Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.

Barth RF, Grecula JC, Yang W, Rotaru JH, Nawrocky M, Gupta N, Albertson BJ, Ferketich AK, Moeschberger ML, Coderre JA, Rofstad EK.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):267-77.

PMID:
14697448
[PubMed - indexed for MEDLINE]
15.

Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.

Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH.

J Neurooncol. 1997 May;33(1-2):59-70.

PMID:
9151224
[PubMed - indexed for MEDLINE]
16.

Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.

Miyata S, Kawabata S, Hiramatsu R, Doi A, Ikeda N, Yamashita T, Kuroiwa T, Kasaoka S, Maruyama K, Miyatake S.

Neurosurgery. 2011 May;68(5):1380-7; discussion 1387. doi: 10.1227/NEU.0b013e31820b52aa.

PMID:
21273928
[PubMed - indexed for MEDLINE]
17.

Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.

Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):663-72.

PMID:
9112465
[PubMed - indexed for MEDLINE]
18.

Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.

Barth RF, Yang W, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.

Cancer Res. 1997 Mar 15;57(6):1129-36.

PMID:
9067283
[PubMed - indexed for MEDLINE]
Free Article
19.

In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.

Tjarks W, Barth RF, Rotaru JH, Adams DM, Yang W, Kultyshev RG, Forrester J, Barnum BA, Soloway AH, Shore SG.

Anticancer Res. 2001 Mar-Apr;21(2A):841-6.

PMID:
11396173
[PubMed - indexed for MEDLINE]
20.

Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy.

Yang FY, Chang WY, Li JJ, Wang HE, Chen JC, Chang CW.

J Nucl Med. 2014 Apr;55(4):616-21. doi: 10.2967/jnumed.113.125716. Epub 2014 Feb 13.

PMID:
24525207
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk